Ayble Health operates a virtual specialty clinic for chronic digestive conditions such as IBS, IBD, acid reflux and SIBO, and is extending its care model into adjacent autoimmune conditions. Patients get unlimited access to a multidisciplinary team of GI-trained clinicians, dietitians, behavioral health specialists, pharmacists and health coaches, with AI-driven personalization built on one of the largest GI datasets, and the company reports 16 peer-reviewed studies validating its outcomes. Founded by IBD patient Sam Jactel and based in Boston, Ayble sells to employers, health plans and health systems, is in-network with most commercial insurers covering more than 80 million Americans, and was nominated for the 2026 Galien Prize.
1
Round
1
Industry
3
Tags
Sep 16, 2026
Latest raise
Funding activity · 1 round
Sep 16, 2026
$16M
Series A
Led by Neon
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
